Pay in 4 interest-free payments of $5.41 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
The KLOW Blend is a four-peptide research formulation combining GHK-Cu (copper tripeptide), BPC-157 (gastric pentadecapeptide), TB-500 (Thymosin Beta-4 fragment), and KPV (alpha-MSH C-terminal tripeptide)
In 20 samples, we identified undeclared API used in PCT
Li YH, He Q, Yu JZ, Liu CY, Feng L, et al
Animal As a senolytic, FOXO4-DRI carries mechanism-specific theoretical risks discussed in the senescence literature including disruption of beneficial senescence surveillance and off-target effects on stem-cell populations that share features with senescent cells and senolytic translation from mouse to human has a history of failures
Angiogenic and growth-factor signaling In rat models of muscle and tendon injury, BPC-157 administration has been associated with up-regulated VEGF expression and accelerated formation of granulation tissue and new microvasculature relative to controls (Brcic et al., 2009
US$ 21.95
US$ 22.20
US$ 27.24
US$ 28.29
US$ 24.79
